NCT06064526View on ClinicalTrials.gov

An Observational, Retrospective Multicentre Medical Record Review to Describe the Post-authorisation Early Clinical Experience of Dupilumab in the Treatment of Adult Severe Asthma

CompletedOBSERVATIONAL
Enrollment

144

Participants

Timeline

Start Date

April 19, 2023

Primary Completion Date

October 15, 2024

Study Completion Date

October 15, 2024

Conditions
Asthma
Interventions
OTHER

No intervention

Non-interventional study based on secondary use of hospital medical records

Trial Locations (1)

91380

Sanofi-Aventis, France, Chilly-Mazarin

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY